Read more
In this issue of
Hematology/Oncology Clinics, guest editor Dr. Elizabeth K. O'Donnell brings her considerable expertise to the topic of
Cancer Precursor Syndromes and Their Detection. Top experts focus on cancer precursors for different sites, with articles on the risk-benefit analysis of early interception; plasma cell precursors; early detection and interception of lung cancer, cervical cancer, GI cancers, skin cancer; and head and neck cancer; biomarkers and early detection; and more.
- Contains 12 relevant, practice-oriented topics including clonal hematopoiesis of indeterminate potential (CHIP); prostate cancer: early detection and intervention; ductal carcinoma in situ; cancer prevention; and more.
- Provides in-depth clinical reviews on cancer precursor syndromes and their detection, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
List of contents
Benefits and Harms of Interception and Early Detection of Cancer
Early Detection of Precursor Diseases of Multiple Myeloma
Early Detection and Interception of Lung Cancer
Cervical Cancer: Precursors and Prevention
Gastrointestinal Cancer Precursor Conditions and Their Detection
Cancer Precursor Syndromes and Their Detection in the Head and Neck
Ductal Carcinoma In Situ
Skin Cancer Precursors: From Cancer Genomics to Early Diagnosis
Biomarkers in Cancer Screening: Promises and Challenges in Cancer Early Detection
